NCT

(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE

NCT is found in 7 entries.

NCT as free ligands, exist in 7 entries. Examples include 1P2Y 1P7R 1UW6

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo



Chemical Component Summary

Name (S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE
Identifiers 3-[(1R,2S)-1-methylpyrrolidin-2-yl]pyridine
Formula C10 H14 N2
Molecular Weight 162.232  g/mol
Type NON-POLYMER
Isomeric SMILES CN1CCC[C@H]1c1cccnc1
InChI InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1
InChIKey SNICXCGAKADSCV-JTQLQIEISA-N

Chemical Details

Formal Charge 0
Atom Count 26
Chiral Atom Count 1
Chiral Atoms C6
Bond Count 27
Aromatic Bond Count 6
Leaving Atoms n/a

Drug Info: DrugBank

DrugBank ID DB00184   (Different stereochemistry)
Name Nicotine
Groups approved
Description Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. [PubChem]
Synonyms
  • (+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine
  • (+-)-Nicotine
  • ()-nicotine
  • (R,S)-nicotine
  • (RS)-nicotine
Salts
  • (+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine
  • (+-)-Nicotine
  • ()-nicotine
  • (R,S)-nicotine
  • (RS)-nicotine
Brand Names
  • American Fare Nicotine Transdermal System
  • Berkley and Jensen Nicotine
  • Berkley and Jensen Nicotine Polacrilex
  • Care One Nicotine
  • Careone Mini Nicotine Polacrilex
Affected Organism Humans and other mammals
Indication For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.
Pharmacology Nicotine, the primary alkaloid in tobacco products binds stereo-selectively to nicotinic-cholinergic receptors on autonomic ganglia, the adrenal medulla, neuromuscular junctions and in the brain. Nicotine exerts two effects, a stimulant effect exerted at the locus ceruleus and a reward effect in the limbic system. Itranvenous administration of nicotine causes release of acetylcholine, norepinephrine, dopamine, serotonine, vasopressin, beta-endorphin and ACTH. Nicotine is a highly addictive substance. Nicotine also induces peripheral vasoconstriction, tachycardia and elevated blood pressure. Nicotine inhalers and patches are used to treat smoking withdrawl syndrome. Nicotine is classified as a stimulant of autonomic ganglia.
Mechanism of action Nicotine is a stimulant drug that acts as an agonist at nicotinic acetylcholine receptors. These are ionotropic receptors composed up of five homomeric or heteromeric subunits. In the brain, nicotine binds to nicotinic acetylcholine receptors on dopaminergic neurons in the cortico-limbic pathways. This causes the channel to open and allow conductance of multiple cations including sodium, calcium, and potassium. This leads to depolarization, which activates voltage-gated calcium channels and allows more calcium to enter the axon terminal. Calcium stimulates vesicle trafficking towards the plasma membrane and the release of dopamine into the synapse. Dopamine binding to its receptors is responsible the euphoric and addictive properties of nicotine. Nicotine also binds to nicotinic acetylcholine receptors on the chromaffin cells in the adrenal medulla. Binding opens the ion channel allowing influx of sodium, causing depolarization of the cell, which activates voltage-gated calcium channels. Calcium triggers the release of epinephrine from intracellular vesicles into the bloodstream, which causes vasoconstriction, increased blood pressure, increased heart rate, and increased blood sugar.
Route of administration
  • buccal
  • nasal
  • oral
  • respiratory (inhalation)
  • topical
Categories
  • Ganglionic Stimulants
  • Nicotinic Agonists
  • Appetite Depressants
  • Autonomic Agents
  • CYP2A6 Substrates
ATC-Code N07BA01
AHFS-Code
  • 12:92.00
  • 24:06.92
  • 88:08.00
  • 92:02.00*
CAS number 54-11-5

Drug Targets

Name Sequence Search Pharmacological Action Actions
Neuronal acetylcholine receptor subunit alpha-6 MLTSKGQGFLHGGLCLWLCVFTPFFKGCVGCATEERLFHKLFSHYNQFIR... unknown agonist
Neuronal acetylcholine receptor subunit alpha-9 MNWSHSCISFCWIYFAASRLRAAETADGKYAQKLFNDLFEDYSNALRPVE... unknown agonist
Choline O-acetyltransferase MGLRTAKKRGLGGGGKWKREEGGGTRGRREVRPACFLQSGGRGDPGDVGG... unknown
Neuronal acetylcholine receptor subunit beta-3 MLPDFMLVLIVLGIPSSATTGFNSIAENEDALLRHLFQGYQKWVRPVLHS... unknown agonist
Neuronal acetylcholine receptor subunit alpha-5 MAARGSGPRALRLLLLVQLVAGRCGLAGAAGGAQRGLSEPSSIAKHEDSL... unknown agonist
View More Drug Targets
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682